A glimmer of hope among those with Alzheimer?s, Parkinson?s, diabetes and other ailments that might be relieved with new treatments derived from embryonic stem cells was dimmed this week by a federal judge, whose injunction on federal funding for such research could not only jeopardize American medical science but the health of millions of patients worldwide. But the failure isn?t just judicial ? the ruling was based in part on a sound interpretation of an ill-considered law imposed by Congress.
Office of Strategic Communication